We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Nursing Perspectives
Video Expert Opinion
Sign in
Join now
featured
Published in Renal Cell Carcinoma and
1 other channel

Expert Opinion / Interview · February 22, 2017

Neoadjuvant Therapy for RCC From ASCO GU 2017: A Review

Interview by
Farzanna S Haffizulla MD, FACP, FAMWA
Interview with
Jose A Karam MD, FACS

 

Save Recommend
Share

Additional Info

Disclosure statements are available on the authors' profiles:

Jose Karam MD, FACS

Further Reading

Most Watched This Week

Related Videos